NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

Kyverna Therapeutics, Inc., a leading biotechnology company focusing on autoimmune diseases, revealed its strategic priorities for the year 2025 and anticipated milestones in a recent press release on ...

The 43 rd Annual Healthcare J.P. Morgan Healthcare Conference kicked off in San Francisco, California earlier this week. Notable executives from analytical science companies were invited to speak ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public ...

San Francisco law enforcement and city leaders are gearing up for a big month ahead and are warning people to be on alert for ...

Reminders of the killing of UnitedHealthcare CEO Brian Thompson were everywhere at this year's J.P. Morgan conference.

Healthcare J.P. Morgan Healthcare Conference kicked off in San Francisco earlier this week. Here’s what top executives from ...

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

SAN FRANCISCO — At the JP Morgan Healthcare Conference here on Wednesday, Myriad Genetics CEO Paul Diaz provided preliminary Q4 and full-year 2024 financial results, as well as full-year 2025 guidance ...